Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease

INTRODUCTION: Synaptic dysfunction and degeneration is one of the earliest events in Alzheimer's disease (AD) and the best correlate of cognitive decline. Thus, identification and validation of biomarkers reflecting synaptic degeneration to be used as prognostic biomarkers are greatly needed. M...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Alzheimers Dement (Amst)
Egile Nagusiak: Nilsson, Johanna, Gobom, Johan, Sjödin, Simon, Brinkmalm, Gunnar, Ashton, Nicholas J., Svensson, Johan, Johansson, Per, Portelius, Erik, Zetterberg, Henrik, Blennow, Kaj, Brinkmalm, Ann
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2021
Gaiak:
Cerebrospinal Fluid Biomarkers
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8087978/
https://ncbi.nlm.nih.gov/pubmed/33969172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12179
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak